➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Moodys
Mallinckrodt
AstraZeneca

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: PALIPERIDONE PALMITATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

PALIPERIDONE PALMITATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264 NDA Janssen Pharmaceuticals, Inc. 50458-560-01 1 SYRINGE in 1 KIT (50458-560-01) > .25 mL in 1 SYRINGE
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264 NDA Janssen Pharmaceuticals, Inc. 50458-561-01 1 SYRINGE in 1 KIT (50458-561-01) > .5 mL in 1 SYRINGE
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264 NDA Janssen Pharmaceuticals, Inc. 50458-562-01 1 SYRINGE in 1 KIT (50458-562-01) > .75 mL in 1 SYRINGE
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264 NDA Janssen Pharmaceuticals, Inc. 50458-563-01 1 SYRINGE in 1 KIT (50458-563-01) > 1 mL in 1 SYRINGE
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264 NDA Janssen Pharmaceuticals, Inc. 50458-563-03 1 SYRINGE in 1 KIT (50458-563-03) > 1 mL in 1 SYRINGE
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Colorcon
Dow